|
|||||
|
|
COVID-19 antibody screening with SARS-CoV-2 red cell kodecytes using routine serologic diagnostic platforms |
|
| Authors: | Radhika Nagappan Willy A. Flegel Kshitij Srivastava Eleanor C. Williams Ivan Ryzhov Alexander Tuzikov Oxana Galanina Nadezhda Shilova Gennady Sukhikh Holly Perry Nicolai V. Bovin Stephen M. Henry |
| Affiliation: | 1. Centre for Kode Technology Innovation, School of Engineering, Computer and Mathematical Sciences, Faculty of Design and Creative Technologies, Auckland University of Technology, Auckland, New Zealand;2. Department of Transfusion Medicine, NIH Clinical Center, National Institutes of Health, Bethesda, Maryland, USA;3. Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia;4. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Moscow, Russia;5. Centre for Kode Technology Innovation, School of Engineering, Computer and Mathematical Sciences, Faculty of Design and Creative Technologies, Auckland University of Technology, Auckland, New Zealand School of Science, Faculty of Health and Environmental Sciences, Auckland University of Technology, Auckland, New Zealand;6. Centre for Kode Technology Innovation, School of Engineering, Computer and Mathematical Sciences, Faculty of Design and Creative Technologies, Auckland University of Technology, Auckland, New Zealand Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia |
| Abstract: | |
| Keywords: | Infectious disease testing intravenous immunoglobulin kodecyte |